Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,148.42
(
0.00%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 83986

Monday, 09/28/2009 1:51:31 PM

Monday, September 28, 2009 1:51:31 PM

Post# of 257580
MNTA’s underwriter exercised the 15% over-allotment option, buying an additional 600K shares @10.75:

http://finance.yahoo.com/news/Momenta-Pharmaceuticals-Inc-pz-2481756629.html?x=0&.v=1

This brings the net proceeds of the latest financing to $46.7M and gives MNTA approximately $108M of cash, as shown in the table in #msg-41810407.

MNTA won’t need to raise again for a long time, if ever.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today